Skip to main content
Premium Trial:

Request an Annual Quote

NIDA to Offer Free DNA Genotyping for Substance Abuse Research

NEW YORK (GenomeWeb) – The National Institute on Drug Abuse is offering researchers free genotyping services for existing extracted DNA samples from individuals with substance abuse disorders, the National Institutes of Health announced last week.

According to the NIDA, the Center for Genetic Studies at the Rutgers University-based biorepository RUCDR Infinite Biologics will genotype samples submitted on BioRealm's SmokeScreen Genotyping array.

The resulting data will be stored in the National Center of Biotechnology Information's database of Genotypes and Phenotypes for six months, during which time the investigators who submitted the samples will be able to analyze their data. After this period, the data will be publicly released per the NIH's Genome Data Sharing Policy.

Requests for genotyping must be received no later than April 1, and proposed samples must be approved by the NIDA, the NIH said. Additional details can be found here.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.